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Background/Aims: The aim of this study was to determine 
whether the routine closure of mucosal defects after endo-
scopic submucosal dissection (ESD) can enhance mucosal 
healing and reduce ESD-associated bleeding. Methods: 
Patients with gastric epithelial neoplasias and no obvious 
submucosal invasion were prospectively enrolled. Mucosal 
defects were left untreated in the control group. In the study 
group, mucosal closure was attempted with a 2-channel 
endoscope, a detachable snare, and clips. All participants 
received a second-look endoscopy the day after ESD, and 
coagulation therapy was administered to patients with vis-
ible vessels and active bleeding points. Results: Fifty-two 
patients were enrolled in the study, and 26 patients were 
assigned to each group. Complete mucosal defect closure 
occurred in 16 patients (61%) in the study group; incomplete 
closure occurred in 8 patients (31%) in the study group, 
and failed closure occurred in 2 patients (8%). Coagulation 
therapy at the second-look endoscopy was performed more 
often in the control group than in the study group (31% vs 
4%, p=0.024). There were no significant differences in the 
incidence of immediate or delayed bleeding or in the two-
week decrease in hemoglobin between the groups. The 
prevalence of open ulcers after 8 weeks was significantly 
lower in the study group than in the control group (18% vs 
43%, p=0.012). Conclusions: Routine mucosal closure after 
ESD supports earlier healing of artiﬁ  cial ulcers. A larger-scale 
trial is necessary to determine whether mucosal closure can 
reduce ESD-associated bleeding. (Gut Liver 2011;5:454-459)
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INTRODUCTION
The development of endoscopic submucosal dissection (ESD) 
has enabled the en bloc resection of larger gastrointestinal 
neoplasms.
1,2 However, ESD-associated complications such as 
perforation and bleeding are still serious considerations. Some 
studies have shown that postoperative bleeding occurs in ap-
proximately 6% to 16% of patients after gastric ESD.
3-5 While 
surgeons almost always approximate and close surgical wounds 
after surgery, a mucosal defect remains following gastric ESD. 
Such defects may be associated with complications such as 
bleeding. 
Mucosal closure with clips is not always feasible, especially 
for larger defects after ESD.
6 However, we have shown that larg-
er mucosal defects can be closed with a two-channel endoscope, 
a detachable snare, and clips.
7 Other researchers have used a 
comparable method to close mucosal defects after colorectal en-
doscopic mucosal resection (EMR).
8
This study was performed to determine whether the routine 
closure of mucosal defects after ESD with a detachable snare 
and clips can enhance mucosal healing, shorten hospital stays, 
and reduce ESD-associated complications. Lee BI, et al: Mucosal Closure after Endoscopic Resection  455
MATERIALS AND METHODS
1. Study subjects
This randomized controlled trial was carried out at Incheon 
St. Mary’s Hospital, The Catholic University of Korea in 
Incheon, Korea between January 2008 and August 2009. The 
protocol was approved by the Institutional Review Board. Eli-
gible patients had gastric epithelial neoplasias (noninvasive low 
grade dysplasia, noninvasive high grade dysplasia, or invasive 
neoplasia without obvious submucosal invasion).
9 The depth of 
invasion was estimated primarily by gross findings. Endoscopic 
ultrasonography (EUS) was performed when the depth of inva-
sion could not be assessed by gross findings only. All biopsy 
specimens from the body and antrum were stained using the 
Warthin-Starry method to identify Helicobacter pylori infection 
at the preoperative endoscopy. 
Patients were excluded from the study if they had received 
anticoagulant, or had a coagulation disorders, end-stage renal 
disease, severe cardiopulmonary disorder, or undifferentiated 
cancer. Patients were also excluded if they were scheduled to 
receive ESD for multiple gastric lesions or a locally recurrent le-
sion after a previous EMR or ESD. Patients were also excluded 
if a clip was applied to control profuse bleeding or to close an 
obvious or impending perforation during the procedure. Pa-
tients with neoplasia at the cardia, fundus, or upper one third 
of corpus were not included because mucosal closure with a 
detachable snare and clips often cannot be performed at those 
locations. 
Antiplatelet agents, including aspirin, were stopped one week 
before ESD and were then withdrawn for three weeks under the 
supervision of the cardiologist or neurologist.
2. ESD
All ESD procedures were performed by one physician (B.W. 
Kim). During the procedure, patients were under conscious se-
dation with midazolam (0.05 mg/kg) and pethidine (50 mg); ad-
ditional doses were given according to the physician’s instruc-
tions.
A conventional gastroscope (GIF-Q240X; Olympus, Tokyo, 
Japan) fitted with a transparent distal attachment (D-201-11304; 
Olympus) was used for the ESD procedures. The margin of the 
tumor was determined by gross findings and indigocarmine 
chromoscopy. Circumferential markings were generated with 
argon plasma coagulation, effect 2 (ARCO 3000; Söring GmbH, 
Quickborn, Germany), 0.5 cm from the margin of the tumor. Af-
ter a mixture of 0.9% normal saline and 0.0005% epinephrine 
was injected into the submucosal layer, a precut was made out-
side the marking with a hook knife (KD-620LR; Olympus) and 
an Endocut-I current (effect 1, duration 3, interval 3; VIO300D; 
ERBE Elektromedizin GmbH, Tübingen, Germany). Submucosal 
dissection was performed mainly with a hook knife and a forced 
coagulation current (effect 2, 40 W). A coagrasper (FD-410LR; 
Olympus) and a soft coagulation current (effect 7, 80 W) was 
primarily used to control bleeding. 
 ESD was performed as extensively as possible for complete 
removal of the lesion. When extreme difficulty was encountered 
during the submucosal dissection for any reason (e.g., severe 
fibrosis or profuse bleeding), snaring with an Endocut-Q current 
was allowed for the final excision. 
 The size of the resected specimen/mucosal defect was mea-
sured with a 3-cm flexible linear probe, and the area was esti-
mated using the formula to calculate the area of an ellipse (1/4×ϖ 
×major axis×minor axis).
3. Mucosal closure
Patients were randomly assigned to either a study group or 
a control group; attempts were made to close mucosal defects 
in the study group, and these defects were left untreated in the 
Fig. 1. Mucosal closure with a de-
tachable snare and clips after endo-
scopic submucosal dissection. (A) A 
mucosal defect remains after ESD. 
(B) A detachable snare is deployed 
on the mucosal defect through a 
working channel, and a rotating 
clip-fixing device with a long clip 
is inserted through the other work-
ing channel. (C) The wire of the 
detachable snare is placed between 
both legs of the clip. (D) The clip is 
applied to the edge of the mucosal 
defect. (E) Another clip is applied 
to the opposite side of the mucosal 
defect in the same manner. (F) The 
snare is squeezed gently, and the 
mucosal defect is approximated. (G) 
Additional clips are applied to close 
the defect. (H) The defect is closed 
completely.456  Gut and Liver, Vol. 5, No. 4, December 2011
control group. Mucosal closure was performed with a double 
channel endoscope (GIF-2T200; Olympus), a detachable snare 
(HX-20Q; Olympus), and clips (HX-610-090L; Olympus) (Fig. 1).
7 
‘Complete closure’ occurred when no submucosa or muscle was 
apparent after the closure (Fig. 2). ‘Incomplete closure’ occurred 
when the mucosal defect was still visible after the procedure but 
had clearly decreased in size. ‘Failed closure’ occurred when the 
size of the mucosal defect could not be decreased using the pro-
cedure. 
4. Post-ESD protocol 
Following the ESD procedure, pantoprazole (40 mg) was ad-
ministered intravenously once a day for 3 days and then given 
to the patients orally. All participants received a second-look 
endoscopy on the day after ESD; during this endoscopy, dehis-
cence of the mucosal closure was assessed, particularly in the 
study group. Visible vessels or active bleeding was treated with 
a coagrasper and soft coagulation as described above. 
Patients who did not receive coagulation therapy at the 
second-look endoscopy were allowed to eat a light meal the day 
after ESD. Those who did receive coagulation therapy were al-
lowed to eat a light meal the day after the therapy. All patients 
were discharged from the hospital the day after oral intake was 
allowed unless they showed any signs or symptoms of com-
plications (i.e., significant changes in vital signs, persistent ab-
dominal pain, or tarry stools). Hemoglobin levels were checked 
daily during admission and a follow-up check was performed 
at the outpatient department 2 weeks after ESD. Pantoprazole 
was maintained for 6 weeks, and a follow-up endoscopy was 
performed 8 weeks after ESD. 
5. Assessment
All specimens were fixed with formalin, cut into 2-mm slices 
and examined. Histological assessment was performed accord-
ing to the Vienna classification of gastrointestinal epithelial 
neoplasia.
9
‘Complete submucosal dissection’ occurred when the lesion 
could be cut off without snaring. ‘En bloc resection’ was defined 
as a single-piece resection of the entire lesion where the rim of 
the artificial ulcer was tumor-free after ESD. ‘Histologic com-
plete resection’ occurred when no neoplasia could be observed 
histologically in the lateral or deep margin of the resected speci-
men. 
Immediate bleeding was defined as either a hemodynamic 
change or a necessary blood transfusion during or within 24 
hours of the procedure. Delayed bleeding was defined as bleed-
ing requiring transfusion or endoscopic hemostasis, or as a 2 
g/dL or more decrease in hemoglobin concentration after 24 
hours.
The ESD procedure time was measured from the insertion of 
the endoscope to its withdrawal and included the mucosal clo-
sure.
At the follow-up endoscopy 8 weeks after ESD, a closed ulcer 
was defined when complete epithelialization was achieved and 
no exudation or fibrin was observed. 
6. Statistical analysis
A chi-square (χ
2) test was used to compare the sex ratio and 
the prevalence of H. pylori infection between the control and 
study groups. Fisher’s exact test was used to compare the fol-
lowing variables between the two groups: recent use of anti-
platelet agents, tumor location, the rate of complete submucosal 
dissection, en bloc resection and histologic complete resection, 
final histology, the frequency of coagulation therapy at the 
second-look endoscopy, and the incidence of immediate and 
delayed bleeding. Fisher’s exact test was also used to examine 
the prevalence of open ulcers at 8 weeks after ESD in relation to 
Fig. 2. The mucosal defect at the gastric angle is closed completely 
with a detachable snare and clips.
Table 1. Baseline Characteristics of the Control and Study Group
Characteristic Control group Study group  p-value 
Sex 
Male 19 (73)  18 (69)
1.000 
Female   7 (27)   8 (31)
Age, yr  63.9±6.8 63.2±7.8 0.720 
Recent use of 
  antiplatelet agents 
0 (0) 1 (4) 1.000 
H. pylori infection  18 (70) 17 (65) 0.768 
Location
Body    8 (31)   7 (27)
0.324 
Angle    3 (11) 1 (4)
Antrum  13 (50) 18 (69)
Pyloric ring  2 (8) 0 (0)
Data are presented as mean±SD or number (%).Lee BI, et al: Mucosal Closure after Endoscopic Resection  457
the completeness of mucosal closure in the study group. 
The Student’s t-test was used to compare age, procedure time, 
and decrease in hemoglobin 2 weeks following ESD. A Wilcox-
on rank sum test was used to compare the area of the resected 
specimen, the area of the mucosal defect, procedure time per 
area of resected specimen, and duration of stay in the hospital 
between the control and study groups. The area of the mucosal 
defect that could be closed completely was also compared with 
the area that could not be closed completely using a Wilcoxon 
rank sum test. 
A p-value of 0.05 was used to denote significance. SPSS ver-
sion 12.0 (SPSS Inc., Chicago, IL, USA) was used for all statisti-
cal calculations. 
RESULTS
Fifty-two patients were enrolled in the study; 26 patients 
were randomly assigned to each group. EUS was performed in 
13 patients (25%), and all the lesions were confined within the 
mucosal layer. There were no significant differences in sex, age, 
recent use of antiplatelet agents, or prevalence of H. pylori in-
fection between the 2 groups. There was also no significant dif-
ference in the location of the neoplasia between the groups (Table 
1). A second-look endoscopy was performed in all patients. A 
follow-up endoscopy was performed 8 weeks after ESD in 81% 
(21/26) of the control group patients and 85% (22/26) of the 
study group patients. 
There were no significant differences in the area of the re-
sected specimen or the mucosal defect between the control and 
study groups. A snare was used at the final stage of dissection 
in one case in each group. En bloc resection was performed 
in all cases, whereas histologic complete resection was not 
achieved in one case in the study group. 
Among the control group, 11 (42%) patients had invasive 
Table 2. Results of ESD between the Control and Study Group
Variable Control group Study group  p-value 
Area of resected specimen, median (range), cm
2  10.3 (2.8–27.0)   7.7 (3.1–24.0) 0.164 
Area of mucosal defect, median (range), cm
2  14.1 (5.9–30.0) 11.0 (4.5–37.7) 0.213 
Complete submucosal dissection  25 (96) 25 (96) 1.000
En bloc resection  26 (100)   26 (100) – 
Histologic complete resection   26 (100) 25 (96) 1.000 
Final histology
Noninvasive low grade neoplasia 11 (42)   6 (23)
0.344 Noninvasive high grade dysplasia    4 (16)   6 (23)
Intramucosal carcinoma 11 (42) 14 (54)
Data are presented as median (range) or number (%).
ESD, endoscopic submucosal dissection.
Table 3. Mucosal Closure and Related Outcomes between the Control and Study Group
Variable Control group Study group  p-value 
Procedure time, mean±SD, min  58.4±26.6 62.2±20.0 0.562 
Elapsed time for mucosal closure, median (range), min - 14.4 (7.4–32.1) -
Procedure time/area of resected specimen, median (range), min/cm
2 4.6 (2.0–26.0)   6.8 (2.9–22.0) 0.026
Mucosal closure, n (%)
Complete 
-
16 (61)
– Incomplete   8 (31)
Failed 2 (8)
Coagulation therapy at the second-look endoscopy, n (%)   8 (31) 1 (4) 0.024
Immediate bleeding, n  0 0 –
Delayed bleeding, n (%) 0 (0) 1 (4) 1.000
Hb decrease 2 wk after ESD, mean±SD, g/dL 0.3±0.7 0.0±0.9 0.273
Hospital stay, median (range), day      4 (3–13)     3 (2–4) 0.000
Open ulcer until 8 wk after ESD, n (%)   9 (43) 2 (9) 0.016
Hb, hemoglobin level; ESD, endoscopic submucosal dissection.458  Gut and Liver, Vol. 5, No. 4, December 2011
neoplasia, whereas 14 (54%) patients presented this condition in 
the study group. However, there was no case with submucosal 
invasion in either group (Table 2). 
Although there was no significant difference in the overall 
procedure time between the control and study groups, there was 
a significant difference in the procedure time per area of re-
sected specimen (Table 3). Among the study group, the mucosal 
defect could be closed completely in 16 cases (61%) and incom-
pletely in 8 cases (31%). Mucosal closure failed in 2 cases (8%) 
because the mucosal edge where the clip was applied tore when 
the snare was squeezed. Among the study group, the median 
area of the mucosal defect that could be closed completely was 
10.1 cm
2 (range, 4.5 to 23.0); the median area of the defect that 
could be closed incompletely or could not be closed was 14.5 
cm
2 (range, 8.2 to 37.7; p=0.053).
At the second-look endoscopy, dehiscence occurred in 3 
(19%) of the 16 patients whose mucosal defects had been closed 
completely. The area of dehiscence was enlarged in 3 (38%) of 
the 8 patients with incompletely closed mucosal defects. Eight 
patients in the control group received coagulation therapy for 
visible vessels or bleeding, while only one study group patient 
required coagulation therapy (31% vs 4%, p=0.024).  
No patients experienced immediate bleeding. One patient in 
the control group developed acute pancreatitis after ESD that 
was resolved with conservative care. Delayed bleeding occurred 
in one study group patient 10 days after ESD; this patient’s 
mucosal defect had been closed completely and the closure 
showed no dehiscence at the second-look endoscopy. However, 
an emergency endoscopy revealed complete dehiscence of the 
closure and black stigmata on the ulcer base. There was no sig-
nificant difference in the 2-week hemoglobin decrease between 
the control and study groups. The length of stay in the hospital 
was significantly shorter in the study group than in the control 
group (median 3 days, 2 to 4 vs. 4 days, 3 to 13; p=0.000). 
There was a significant difference in the prevalence of open 
ulcers 8 weeks after ESD between the control and study groups 
(43% vs 18%, p=0.012). However, in the study group, no sig-
nificant relationship was observed between the prevalence of 
open ulcers 8 weeks after ESD and the completeness of mucosal 
closure (complete closure 8% vs incomplete closure 14% vs 
failed closure 0%; p=1.000). 
One or two clips remained in 9 patients (41%) from the study 
group and no tumor recurrence was observed within 8 weeks 
after ESD in either the control or study groups. 
DISCUSSION
We hypothesized that immediate closure of the artificial ul-
cer by ESD would decrease exposure of the submucosal vessels 
to gastric acid, pepsin, and mechanical stimuli and, therefore, 
would decrease ESD-associated bleeding. However, this study 
failed to confirm that routine mucosal closure after ESD can 
reduce ESD-associated bleeding. Only one case of bleeding (2%) 
occurred among 52 ESD procedures; this rate is much lower 
than the bleeding rates reported in other studies.
3-5 It is well 
known that proton pump inhibitors (PPIs) effectively prevent 
bleeding from the ulcer created after ESD,
10,11 and in this study, 
a standard dose of pantoprazole was given to all participants 
intravenously for 3 days and then orally for 6 weeks. Coagula-
tion therapy at the second-look endoscopy might also decrease 
bleeding rates in this study, although there is some debate over 
whether a second-look endoscopy after gastric ESD can contrib-
ute to the prevention of delayed bleeding.
4 In addition, patients 
with a high risk of bleeding (i.e., those who received antico-
agulation therapies, who have coagulation disorders, end stage 
renal disease, severe cardiopulmonary disease, or who required 
the application of clips to control profuse bleeding during sub-
mucosal dissection) were excluded from the study; these exclu-
sions may have decreased the bleeding rate observed in the 
study. Small numbers of the subjects in each group is another 
limitation of the study.
Active bleeding or visible vessels were infrequently observed 
in the study group at the second-look endoscopy, and therefore, 
coagulation therapy was rarely necessary. However, stigmata 
might be covered by the mucosal closure in the study group. 
Finally, there was no significant difference in the incidence of 
immediate or delayed bleeding or in the hemoglobin decrease 
between the groups. 
It is not conclusive that mucosal closure shortened hospital 
stay even though the duration was significantly shorter in the 
study group than in the control group. Patients who received 
coagulation therapy were allowed a meal 1-day later than those 
who did not, therefore the result of the second-look endoscopy 
might play as a primary determinant of hospital stay. In addi-
tion, the patient who developed acute pancreatitis in the control 
group was admitted for 13 days.
However, the present study did demonstrate that mucosal 
closure after ESD facilitated healing of the artificial ulcer. When 
the continuity of the mucosal epithelium of the gastrointestinal 
tract is disrupted, a process called ‘restitution’ occurs as viable 
epithelial cells migrate from areas adjacent to the injured sur-
face to re-establish a barrier to the noxious substances within 
the lumen.
12,13 Approximation with a detachable snare and clips 
is comparable to restitution because the process forces the mi-
gration of the mucosal layer to the artificial ulcer and reseals 
the barrier. 
The prevalence of open ulcer 8 weeks after ESD in the control 
group seems to be higher than those in other studies.
14,15 This 
may be because H3 stage ulcers were considered as open ulcers 
in this study and PPI was discontinued 2 weeks before a follow 
endoscopy.
One potential concern is that mucosal closure after ESD could 
conceal local recurrence of the tumor. However, there is cur-
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local recurrence. When the resection margin is involved by the 
tumor, it is common practice in Korea and Japan to perform an 
additional endoscopic resection to prevent local recurrence. We 
consider it probable that the mucosal closure with a detachable 
snare and clips could be easily reopened for additional resection 
by the time the histopathologic report is available (3 to 5 days 
after ESD). A lateral resection margin was positive in a 50-year-
old male with intramucosal carcinoma in the study group; how-
ever no remaining tumor was found at the second-look endos-
copy, and the patient wanted only to be followed closely; there 
was no recurrence until the 6-month follow-up endoscopy. 
The use of a detachable snare and clips is not always feasible 
in some locations and for large mucosal defects. Tumors located 
at the proximal stomach were excluded from the study because 
we recognized the use of this method was difficult at proxi-
mal locations during the pilot study period.
7 Nevertheless, the 
mucosal defect could be closed completely only in 61% of the 
patients in the study group. Early dehiscence is another limita-
tion. In addition, mucosal closure with a detachable snare and 
clips is a time-intensive procedure; a significant difference was 
observed in procedure time per area of resected specimen be-
tween the control and study groups. More effective methods are 
expected to be developed in the future. 
We did not observe significant differences in the prevalence 
of open ulcers 8 weeks after ESD according to the complete-
ness of mucosal closure in the study group. We postulate that 
this finding is mainly a result of the small numbers included in 
each subgroup among the study group patients who received a 
follow-up EGD (i.e., 13 patients with complete closure, 7 with 
incomplete closure, and 2 with failed closure). One limitation 
of the study is that we did not examine subjective symptoms, 
including pain after ESD.
In summary, the results of this study demonstrated that rou-
tine mucosal closure after gastric ESD can facilitate earlier heal-
ing of the mucosal defect. Larger-scale trials with different pro-
tocols are needed to further examine whether mucosal closure 
can reduce ESD-associated complications such as bleeding. 
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